W77-20501-94075
2 vaccinations
1 coded response
24 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 05-11
- ZIP prefix
- 840 / UT
- Registered
- 2021-11-13
- Relationship
- Child or adolescent in my care
- Guardian
- G37-31375-73900
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-11-13
Registered in v-safe
-
2021-11-13
Dose 1 — Pfizer-BioNTech
- 2021-11-13
- 2021-11-14
- 2021-11-15
- 2021-11-16
- 2021-11-17
- 2021-11-18
- 2021-11-19
- 2021-11-20
- 2021-11-27
- 2021-12-04
-
2021-12-07
Dose 2 — Pfizer-BioNTech
- 2021-12-08
- 2021-12-09
- 2021-12-11
- 2021-12-12
- 2021-12-13
- 2021-12-14
-
2021-12-21
Survey response — day 14, dose 2, dependentMedDRA: Headache, Respiratory tract congestion, Rhinorrhoea — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Maybe have a cold? Runny nose, chest congestion, headache.MedDRA releases: 2024-11 · check-in free text available
- 2021-12-30
- 2022-01-06
- 2022-01-11
- 2022-01-18
- 2022-03-08
- 2022-06-07
- 2022-12-07
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-11-13 | Pfizer-BioNTech | No |
| 2 | 2021-12-07 | Pfizer-BioNTech | No |
Free text
Release 10 — day 14, dose 2, dependent
Symptoms: Maybe have a cold? Runny nose, chest congestion, headache.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Headache | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release